Effect of ziprasidone dose on rates of medication discontinuation in acute schizophrenia or schizoaffective disorder

被引：0
|
作者：
Karayal, O.
Citrome, L. [2 ]
Yang, R. [1 ]
Harnett, J. [3 ]
Glue, P. [4 ]
机构：
[1] Pfizer Inc, Statistics, New York, NY USA
[2] Nathan S Kline Inst Psychiat Res, New York, NY USA
[3] Pfizer Inc, Global Outcomes, New York, NY USA
[4] Pfizer Inc, Clin Sci Grp, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：160 / 160
页数：1
相关论文
共 50 条
  • [1] Effect of ziprasidone dose on rates of medication discontinuation in acute schizophrenia or schizoaffective disorder
    Citrome, Leslie
    Yang, Ruoyong
    Harnett, James
    Glue, Paul
    Karayal, Onur
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 285S - 285S
  • [2] Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: A post-hoc analysis of 4 fixed-dose randomized clinical trials
    Citrome, Leslie
    Yang, Ruoyong
    Glue, Paul
    Karayal, Onur N.
    SCHIZOPHRENIA RESEARCH, 2009, 111 (1-3) : 39 - 45
  • [3] Spotlight on Ziprasidone in Schizophrenia and Schizoaffective Disorder
    Nishan S. Gunasekara
    Caroline M. Spencer
    Gillian M. Keating
    CNS Drugs, 2002, 16 : 645 - 652
  • [4] Spotlight on ziprasidone in schizophrenia and schizoaffective disorder
    Gunasekara, NS
    Spencer, CM
    Keating, GM
    CNS DRUGS, 2002, 16 (09) : 645 - 652
  • [5] Ziprasidone in early onset schizophrenia and schizoaffective disorder
    Ambler, Denisse
    Maloney, Ann
    Hunt-Harrison, Tyehimba
    Andersson, Robert
    Magers, Steve
    Hamer, Robert M.
    Findling, Robert
    Frazier, Jean
    McClellan, Jon
    Sikich, Linmarie
    Lieberman, Jeffrey A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (06) : 652 - 652
  • [6] Ziprasidone in early onset schizophrenia and schizoaffective disorder
    Ambler, DML
    Maloney, AE
    Hunt-Harrison, T
    Andersson, R
    Magers, S
    Findling, R
    Frazier, JA
    McClellan, J
    Hamer, R
    Sikich, L
    Lieberman, JA
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 55S - 56S
  • [7] Ziprasidone: zealous in the treatment of schizophrenia and schizoaffective disorder
    Drugs & Therapy Perspectives, 2003, 19 (4) : 1 - 4
  • [8] Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder
    Robinson, DG
    Woerner, MG
    Alvir, JMJ
    Bilder, RM
    Hinrichsen, GA
    Lieberman, JA
    SCHIZOPHRENIA RESEARCH, 2002, 57 (2-3) : 209 - 219
  • [9] Ziprasidone and risperldone equally efficacious for treatment of acute exacerbation of schizophrenia or schizoaffective disorder
    不详
    FORMULARY, 2005, 40 (03) : 92 - 93
  • [10] Ziprasidone - A review of its use in schizophrenia and schizoaffective disorder
    Gunasekara, NS
    Spencer, CM
    Keating, GM
    DRUGS, 2002, 62 (08) : 1217 - 1251
12345